Stereotaxis Inc. (NYSEAMERICAN:STXS – Get Free Report) Director Arun Swarup Menawat acquired 121,561 shares of the company’s stock in a transaction that occurred on Tuesday, November 17th. The stock was purchased at an average cost of $0.82 per share, with a total value of $99,680.02. Following the completion of the purchase, the director directly owned 1,157,121 shares in the company, valued at $948,839.22. This represents a 11.74% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Stereotaxis Trading Up 6.8%
NYSEAMERICAN:STXS opened at $1.01 on Friday. The company has a market capitalization of $101.20 million, a PE ratio of -4.21 and a beta of 1.40. The company has a quick ratio of 0.95, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. Stereotaxis Inc. has a 52-week low of $0.80 and a 52-week high of $2.86. The stock has a fifty day simple moving average of $1.09 and a 200-day simple moving average of $1.60.
Stereotaxis (NYSEAMERICAN:STXS – Get Free Report) last announced its earnings results on Tuesday, November 10th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). Stereotaxis had a negative return on equity of 125.27% and a negative net margin of 70.86%. The business had revenue of $8.93 million for the quarter, compared to analyst estimates of $9.60 million. On average, equities research analysts expect that Stereotaxis Inc. will post -0.23 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the company. TD Cowen reduced their price target on Stereotaxis from $3.00 to $2.00 and set a “buy” rating on the stock in a research note on Wednesday, November 11th. Citizens Jmp lowered their price objective on Stereotaxis from $4.00 to $3.00 and set a “market outperform” rating for the company in a research report on Thursday, August 27th. Finally, Citigroup reiterated an “outperform” rating on shares of Stereotaxis in a research note on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $2.83.
Get Our Latest Stock Analysis on Stereotaxis
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the business. Integrity Alliance LLC. acquired a new stake in Stereotaxis in the third quarter valued at approximately $860,000. Bank of New York Mellon Corp acquired a new position in shares of Stereotaxis during the second quarter worth $364,000. Sei Investments Co. lifted its position in shares of Stereotaxis by 108.9% during the first quarter. Sei Investments Co. now owns 518,884 shares of the company’s stock worth $955,000 after purchasing an additional 270,443 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Stereotaxis by 40.2% in the third quarter. Goldman Sachs Group Inc. now owns 329,420 shares of the company’s stock valued at $405,000 after purchasing an additional 94,449 shares during the period. Finally, Cetera Investment Advisers purchased a new position in shares of Stereotaxis in the third quarter valued at $60,000. Hedge funds and other institutional investors own 45.35% of the company’s stock.
About Stereotaxis
Stereotaxis develops robotic technologies for minimally invasive procedures, with a focus on treating heart rhythm disorders. Its systems are designed to help physicians guide catheters through blood vessels and within the heart during procedures such as cardiac ablation. The company’s products include the Genesis Robotic Magnetic Navigation System, which uses externally controlled magnetic fields to steer compatible catheters, and the Odyssey platform for managing and displaying information in interventional procedure rooms.
Recommended Stories
- Five stocks we like better than Stereotaxis
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.
